Medical
Accelerating Production
April 16, 2012 1:00 pm | by Jonnatha Mayberry, Associate Editor, Chem.Info | Articles | CommentsUnable to produce much-needed vaccines with its limited production capacity, Merck decided to rapidly increase its manufacturing capabilities.
Engineering The Future
April 13, 2012 12:34 pm | by Mike Auerbach, Editor in Chief, Pharmaceutical Processing | Blogs | CommentsWhen designing pharmaceutical facilities, there is much to be taken into consideration, and merely throwing up a "bunch of bricks" just doesn't cut it anymore.
FDA Adds New Side Effects To Finasteride Label
April 12, 2012 2:49 pm | News | CommentsThe main ingredient in the male baldness treatment Propecia is responsible, the FDA says, for side effects that linger after patients stop taking the drug.
Amgen To Buy KAI Pharma For $315M
April 10, 2012 1:48 pm | News | CommentsThe world's biggest biotech drugmaker will help KAI finish planning late stage trials of its most advanced drug candidate, which helps dialysis patients.
Cook Group Acquires Biotech Company
April 10, 2012 9:05 am | News | CommentsMedical device maker Cook Group has bought an Indianapolis company that specializes in cell and tissue processing and cryopreservation technologies.
FDA Finds More Vials Of Fake Cancer Drug
April 4, 2012 1:17 pm | News | CommentsThe vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S.
Medtronic Pays $85M To End Shareholder Lawsuit
April 2, 2012 8:58 am | News | CommentsMedical device maker Medtronic Inc. has agreed to pay $85 million to resolve a federal class action lawsuit brought by a group of shareholders.
Roche Raises Bid For Illumina
March 29, 2012 9:11 am | News | CommentsSwiss pharmaceutical company raised its offer for Illumina to $51 cash per share, in a bid to speed up a takeover of the U.S. diagnostics company.
Allergan Says Botox Works In Incontinence Study
March 28, 2012 2:25 pm | News | CommentsIn a recent test, the popular wrinkle remover and spasm suppressant worked better than a placebo as a treatment for an overactive bladder.
Cypress Pharma Settles Marketing Case For $2.8M
March 28, 2012 2:00 pm | News | CommentsThe government alleges that a Cypress subsidiary falsely claimed that three skin products carried the FDA's "safe and effective" designation.
Trial Begins In Arkansas Over Anti-Psychotic Drug
March 27, 2012 2:18 pm | by Allen Reed, Associated Press | News | CommentsAn attorney has asked jurors to hold a J&J subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.
Ala. Judge Sets Trial Dates For Suits Over Chantix
March 27, 2012 9:41 am | News | CommentsThe first two trials of more than 2,400 lawsuits nationwide accuse the drug, which was made by Pfizer, of causing the patient to commit suicide.
FDA Outlines MAP Inc. Drug Issues
March 27, 2012 9:28 am | News | CommentsThe FDA asked the Mountain View, Calif.-based company to address "observations from a recent facility inspection of a third party manufacturer."
Bausch & Lomb To Buy Ista Pharma For $500M
March 27, 2012 9:13 am | News | CommentsEye-health company Bausch & Lomb plans to buy eye-drug maker Ista Pharmaceuticals Inc. for about $500 million in cash.
Device Maker Biomet Paying $22.7M For Bribery
March 26, 2012 2:38 pm | News | CommentsThe Warsaw, Ind.-based medical device maker won't be prosecuted by the Justice Department if it institutes strict internal controls to prevent bribery.
Covidien Buying Newport Medical Instruments
March 23, 2012 9:08 am | News | CommentsIrish drug and medical device maker Covidien PLC said it is buying ventilator maker Newport Medical Instruments Inc. for about $108 million.
Lawmakers: Fake Pharmacies Price Gouging On Drugs
March 22, 2012 9:18 am | by Linda A. Johnson, AP Business Writer | News | CommentsMembers of Congress say these groups are playing a "shell game" — to make money by taking advantage of the drug shortage crisis.
Medical Product Company To Bring Auburn 300 Jobs
March 21, 2012 9:56 am | News | CommentsSiO2 Medical Products is investing $90 million in the Alabama plant, which will make products for the biological drugs industry.
MIT: Continuous Drug Manufacturing Offers Speed, Lower Costs
March 20, 2012 10:49 am | by Anne Trafton, MIT News | News | CommentsInstead of manufacturing drugs using a conventional batch-based system, MIT and Novartis envisioned a continuous manufacturing process, all done in one location, which would cut down on time and cost.
Covidien Buying superDimension For About $300M
March 19, 2012 9:12 am | News | CommentsIrish medical device and drug maker agreed to buy Israel-based superDimension Ltd. for about $300 million initially plus possible future payments.
J&J CEO Get Raise To $21.6M Despite Recalls
March 14, 2012 3:09 pm | by Linda A. Johnson, AP Business Writer | News | CommentsWilliam Weldon, who will step down next month after a decade as CEO, oversaw about 30 product recalls since 2009, which cost about $1 billion.
FTC Asks Roche For Details On Illumina Offer
March 14, 2012 9:26 am | News | CommentsIllumina's board unanimously turned down Roche's hostile takeover offer last month, saying it was "grossly inadequate."
FDA Panel Supports Continued Testing Of Pain Drugs
March 13, 2012 9:28 am | by Matthew Perrone, AP Health Writer | News | CommentsDrugmakers tout the nerve growth factor inhibitors as a breakthrough for treating chronic pain, but those in previous studies reported bone decay and joint failure.
British Doctors Urge Against Metal Hip Joints
March 13, 2012 9:24 am | by Maria Cheng, AP Medical Writer | News | CommentsBritish experts at the world's biggest artificial joint registry said metal versions have to be fixed or replaced more often than other implants.
Japan's Asahi Kasei Buying Zoll Medical
March 13, 2012 9:05 am | News | CommentsJapanese chemical manufacturer has agreed to buy Zoll Medical Corp, which makes defibrillators and other critical care medical devices, for about $2.2 billion.
